Survival of patients with neck recurrence following radical neck dissection: Utility of a second neck dissection?

Head and Neck

Volumn 30, Issue 11, 2008, Pages 1514-1522

  Jones, Andrew S ^a   Tandon, Sankalap ^a,b   Helliwell, Timothy R ^a   Husband, David J ^c   Jones, Terence M ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^c CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

Author keywords

Head and neck; Radical neck dissection; Recurrence; Salvage surgery; Squamous cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HYPOPHARYNX CANCER; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; NECK DISSECTION; OROPHARYNX CANCER; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RISK ASSESSMENT; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; RISK FACTORS; SALVAGE THERAPY; SURVIVAL ANALYSIS;

EID: 55549130309     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20860     Document Type: Article

References (38)

1. Crile GW. Excision of cancer of the head and neck with special reference to the plan of dissection based on 132 patients. J Am Med Assoc 1906;47:1780-1786.
2. Stell PM, Maran AGD. Head and neck surgery. London: William Heinemann Medical Books Ltd; 1980. 456 p.
3. Jones AS, Roland NJ, Field JK, Phillips DE. The level of cervical lymph node metastases: their prognostic relevance and relationship with head and neck squamous carcinoma primary sites. Clin Otolaryngol 1994;19:63-69.
4. Gamel JW, Jones AS. Squamous carcinoma of the head and neck: cured fraction and survival times as functions of age, sex, histologic type and node status. Br J Cancer 1993;67:1071-1075.
5. Violaris NS, O'Neill D, Helliwell TR, Caslin AW, Roland NJ, Jones AS. Soft tissue cervical metastases of squamous carcinoma of the head and neck. Clin Otolaryngol 1994;19:394-399.
6. Jones AS, Houghton DJ, Beasley NJ, Husband DJ. Improved survival in patients with head and neck cancer in the 1990s. Clin Otolaryngol 1998;23:319-325.
7. Jones AS, Phillips DE, Helliwell TR, Roland NJ. Occult node metastases in head and neck squamous carcinoma. Eur Arch Otorhinolaryngol 1993;250:446-449.
8. Jones AS. Prognosis in mouth cancer: tumour factors. Eur J Cancer B Oral Oncol 1994;30B:8-15.
9. Jones AS, Husband D, Rowley H. Radical radiotherapy for squamous cell carcinoma of the larynx, oropharynx and hypopharynx: patterns of recurrence, treatment and survival. Clin Otolaryngol 1998;23:496-511.
10. Braun S, Pantel K, Muller P, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000;342: 525-533.
11. Hermanek P, Sobin LH. UICC TNM classification in malignant tumours. Berlin: Springer-Verlag; 1992.
12. Beahrs OH, Henson DE, Hutter RVP, Myers MH. General rules for cancer staging: Eastern Co-operative Oncology Group Scale. Manual for staging of cancer (AJCC). Philadelphia: Lippincott; 1988. p 9.
13. Jones AS, Cook JA, Phillips DE, Roland NJ. Squamous carcinoma presenting as an enlarged cervical lymph node. Cancer 1993;72:1756-1761.
14. SAS Institute Inc. Users guide: statistics version, 5th ed. North Carolina: SAS Institute; 1985.
15. Armitage P, Berry G. Survival analysis. In: Armitage P, Berry G, editors. Statistical methods in medical research. Oxford: Blackwell; 1987. pp 421-439.
16. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc B 1972;4:187-220.
17. Petruzzelli GJ, Benefield J, Yong S. Mechanism of lymph node metastases: current concepts. Otolaryngol Clin North A 1998;31:585-599.
18. Quabain SW, Natsugoe S, Matsumoto M, et al. Micrometastases in the cervical lymph nodes in oesophageal squamous cell carcinoma. Dis Oesophagus 2001;14:143-148.
19. Erdamar B, Süogiu Y, Kiyak E, Güven M, Hafiz G, Asian I. Metastasis to infraclavicular lymph nodes in head and neck cancer: a report of three cases. Kulak Burun Bogaz Ihtis Derg 2002;9:368-371.
20. Koch WM. Axillary nodal metastases in head and neck cancer. Head Neck 1999;21:269-272.
21. Rayatt SS, Dancey AL, Fagan J, Srivastava S. Axillary metastases from recurrent oral carcinoma. Br J Oral Maxillofac Surg 2004;42:264-266.
22. Kowaiski LP. Noncervical lymph node metastasis from head and neck cancer. ORL J Otorhinolaryngol Relat Spec 2001;63:252-255.
23. Layland MK, Sessions DG, Lenox J. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope 2005;115: 629-639.
24. Stoeckli SJ, Pawlik AB, Lipp M, Huber A, Schmid S. Salvage surgery after failure of nonsurgical therapy for carcinoma of the larynx and hypopharynx. Arch Otolaryngol Head Neck Surg 2000;126:1473-1477.
25. Godden DR, Ribeiro NF, Hassanein K, Langton SG. Recurrent neck disease in oral cancer. J Oral Maxillofac Surg 2002;60:748-753; discussion 753-755.
26. Koo BS, Lim YC, Lee JS, Choi EC. Recurrence and salvage treatment of squamous cell carcinoma of the oral cavity. Oral Oncol 2006;42:789-794.
27. Kim AJ, Suh JD, Sercarz JA, et al. Salvage surgery with free flap reconstruction: factors affecting outcome after treatment of recurrent head and neck squamous carcinoma. Laryngoscope 2007;117:1019-1023.
28. Stafford N, Dearnaley D. Treatment of 'inoperable' neck nodes using surgical clearance and postoperative interstitial irradiation. Br J Surg 1988;75:62-64.
29. Jeong WJ, Jung YH, Kwon SK, et al. Role of surgical salvage for regional recurrence in laryngeal cancer. Laryngoscope 2007;117:74-77.
30. Kuss I, Hathaway B, Ferris RL, Gooding W, Whiteside TL. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res 2004;10:3755-3762.
31. Katayma A, Bandoh N, Kishibe K, et al. Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumour metastases and prognosis. Clin Cancer Res 2004;10:634-640.
32. Krimmel M, Hoffmann J, Krimmel C, Cornelius CP, Schwenzer N. Relevance of SSC-Ag, CEA, CA 125 for diagnosis and follow up in oral cancer. J Craniomaxillofac Surg 1998;26:243-248.
33. Tomura N, Watanabe O, Hirona Y, Kato K, Takahashi S, Watarai J. MR imaging of recurrent had and neck tumours following flap reconstructive surgery. Clin Radiol 2002;57:109-113.
34. Leitha T, Glaser C, Prukmayer M, et al. Technetium-99m-MIBI in primary and recurrent head and neck tumours: contribution of bone SPECT image fusion. J Nucl Med 1998;39:1166-1171.
35. Schmidt M, Schmalenbach M, Jungehulsing M, et al. 18F-FDG PET for detecting recurrent head and neck cancer, local lymph node involvement and distant metastases. Comparison of qualitative visual and semiquantitative analysis. Nuklearmedizin 2004;43:102-104.
36. Johnson JT, Wagner RL, Myers EN. A long-term assessment of adjuvant chemotherapy on outcome of patients with extracapsular spread of cervical metastases from squamous carcinoma of the head and neck. Cancer 1996;77:181-185.
37. Cortesina G, De Stefani A, Glovarelli M, et al. Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of interleukin-2 injected perilymphatically. Cancer 1988;62:2483-2485.
38. To WC, Wood BG, Krauss JC, et al. Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck: a phase 1 study. Arch Otolaryngol Head Neck Surg 2000;126:1225-1231.